Therapeutics Acquisition Corp. (59) | Human Resources (21)
Browse by Subcategory
Recent Contracts
-
Form of Performance Stock Unit Award under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan
(Filed With SEC on March 27, 2023)
-
Consulting Agreement effective January 1, 2022 by and between POINT Biopharma Inc. and Dr. Neil Fleshner
(Filed With SEC on March 25, 2022)
-
Employment Agreement effective December 1, 2021, as amended, by and between POINT Biopharma USA Inc. and Justyna Kelly
(Filed With SEC on March 25, 2022)
-
Revised Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan
(Filed With SEC on December 10, 2021)
-
POINT Biopharma Global Inc. 2021 Equity Incentive Plan
(Filed With SEC on July 1, 2021)
-
Form of Incentive Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan
(Filed With SEC on July 1, 2021)
-
Form of Restricted Stock Unit Award Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Directors)
(Filed With SEC on July 1, 2021)
-
Form of Restricted Stock Unit Award Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Employees)
(Filed With SEC on July 1, 2021)
-
Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Directors)
(Filed With SEC on July 1, 2021)
-
Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Employees)
(Filed With SEC on July 1, 2021)
-
2020 POINT Biopharma, Inc. Equity Incentive Plan
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Allan Silber, as amended March 8, 2021
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Ari Shomair, as amended March 8, 2021
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of November 2, 2020, by and between POINT Biopharma Corp. and Justyna Kelly, as amended March 8, 2021
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of July 19, 2020, by and between POINT Biopharma USA Inc. and Jessica Jensen
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma USA Inc. and Todd Hockemeyer
(Filed With SEC on March 23, 2021)
-
Consulting Agreement by and between POINT Biopharma Inc. and Dr. Neil Fleshner, dated February 22, 2021
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Michael Gottlieb, as amended March 8, 2021
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of July 24, 2020, by and between POINT Biopharma Corp. and William Demers, as amended March 8, 2021
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Joe McCann, as amended March 8, 2021
(Filed With SEC on March 23, 2021)
-
Employment Agreement, dated as of March 9, 2021, by and between POINT Biopharma Corp. and Donna Husack
(Filed With SEC on March 23, 2021)